When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CKDXY - Opthea's OPT-302 shows positive effect in mid-stage wet AMD study
Opthea Ltd ADR
Opthea Limited (OTCPK:CKDXY) announces additional data from a Phase 2b clinical trial evaluating the combination of OPT-302 and Roche's (OTCQX:RHHBY) Lucentis (ranibizumab) compared to Lucentis alone in wet AMD patients. The results were presented at the European Society of Retina Specialists Congress in Paris.
More news on: Opthea Limited, Roche Holding AG, Healthcare stocks news,